Dirk Schadendorf

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, Ruhrlandklinik, National Center for Tumor Diseases, Essen University Hospital, West German Heart and Vascular Center Essen, Deutsches Konsortium für Translationale Krebsforschung, University of Duisburg-Essen · ORCID：0000-0003-3524-7858

发表论文 2401 篇 · 总被引 221503 次 · h-index 182

代表论文

• Explainable AI Predicts Hematoxicity from Cancer Treatment Using Multimodal Real-World Data (2026 · medRxiv · 被引 1)
• COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600–Mutant Advanced Melanoma (2026 · Journal of Clinical Oncology)
• Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial (2026 · Journal of Clinical Oncology)
• Biodistribution, shedding, and transmissibility of vusolimogene oderparepvec (RP1) (2026 · Frontiers in Oncology)
• An explainable transformer model learning from entire treatment timelines for pan-cancer risk profiling across healthcare systems (2026 · medRxiv)
• LLM-Generated Lay-Language Protocols for Molecular Tumor Board Patients: Evaluation of Quality and Clinical Usability (2026 · Journal of Medical Internet Research)